Effect of S‐1 on survival outcomes in 838 patients with advanced pancreatic cancer: A 7‐year multicenter observational cohort study in Taiwan-Reference-Cited by-同舟云学术

Effect of S‐1 on survival outcomes in 838 patients with advanced pancreatic cancer: A 7‐year multicenter observational cohort study in Taiwan

Published:2019-04-18 Issue:5 Volume:8 Page:2085-2094
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Lai Hsiang‐Lan¹,Chen Yen‐Yang¹,Lu Chang‐Hsien²,Hung Chia‐Yen³⁴⁵^ORCID,Kuo Yung‐Chia³⁴,Chen Jen‐Shi³⁴,Hsu Hung‐Chih³⁴^ORCID,Chen Ping‐Tsung²,Chang Pei‐Hung⁶,Hung Yu‐Shin⁷,Chou Wen‐Chi³⁴

Affiliation:

1. Division of Oncology Chang Gung Memorial Hospital at Kaohsiung Kaohsiung Taiwan

2. Division of Oncology Chang Gung Memorial Hospital at Chiayi Chiayi Taiwan

3. Division of Oncology Chang Gung Memorial Hospital at Linkou Taoyuan Taiwan

4. College of Medicine Chang Gung University Taoyuan Taiwan

5. Department of Hema‐oncology, Division of Internal Medicine Mackay Memorial Hospital Taipei Taiwan

6. Division of Oncology Chang Gung Memorial Hospital at Keelung Keelung Taiwan

7. Division of Hematology Chang Gung Memorial Hospital at Linkou Taoyuan Taiwan

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2094

Reference33 articles.

1. Cancer statistics, 2019

2. Health registry annual Report 2013 Republic of China.Republic of China:Bureau of Health Promotion Department of Health Executive Yuan;2015.http://www.hpa.gov.tw/BHPNet/Web/Stat/Statistics.aspx. Accessed July 20 2018.

3. Incidence and survival of adult cancer patients in Taiwan, 2002–2012

4. Incidence and mortality of pancreatic cancer on a rapid rise in Taiwan, 1999–2012

5. Resection versus other treatments for locally advanced pancreatic cancer;Gurusamy KS;Cochrane Database Syst Rev,2014

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of previous S-1 treatment on efficacy of liposomal irinotecan plus 5-fluorouracil and leucovorin in patients with metastatic pancreatic cancer;Pancreatology;2024-03

2. Noninvasive prognostic biomarker potential of quantifying the propeptides of Type XI collagen alpha‐1 chain ( PRO‐C11 ) in patients with pancreatic ductal adenocarcinoma;International Journal of Cancer;2021-03-22

3. Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study;Therapeutic Advances in Medical Oncology;2021-01

4. External validation of the Besançon nomogram in Asian patients with advanced pancreatic cancer receiving second-line chemotherapy: A multi-institute experience in Taiwan;Pancreatology;2020-01

5. S-1–Associated Hypertriglyceridemia in a Patient With Pancreatic Adenocarcinoma;JCO Oncology Practice;2020-01